DrugPatentWatch Database Preview
CLINICAL TRIALS PROFILE FOR METHAZOLAMIDE
Clinical Trials for Methazolamide
| Trial ID | Title | Status | Sponsor | Phase | Summary |
|---|---|---|---|---|---|
| NCT00257829 | Improving Tumor Oxygenation in Cervical Cancer | Withdrawn | University of California, Irvine | Phase 2 | The Phenomenon of Tumor Hypoxia Many solid tumors are relatively resistant to treatment with ionizing radiation and certain chemotherapeutic agents such as anthracyclines that are affected adversely by acidic pH. These effects have primarily been attributed to the presence of hypoxic cells within the tumor. The relevance of hypoxia with respect to failure of radiotherapy to cure certain malignancies has had a chequered history. However, in recent years the evidence that hypoxia plays a central role in relative radioresistance has become more compelling. Since approximately two-thirds of all women suffering from cervical carcinoma receive radiation as a component of their therapy, an enhanced understanding of the interactions between hypoxia and radiation as a component of their therapy, an enhanced understanding of the interactions between hypoxia and radiation resistance is critical to improving outcome among those with cervical cancer. |
| NCT01587027 | Safety Evaluation of Aminophylline and Methazolamide | Completed | Defense Advanced Research Projects Agency | Phase 1 | This safety study is the first in a series of studies testing the application of the combination of aminophylline and methazolamide. |
| NCT01587027 | Safety Evaluation of Aminophylline and Methazolamide | Completed | University of Colorado, Denver | Phase 1 | This safety study is the first in a series of studies testing the application of the combination of aminophylline and methazolamide. |
| NCT01587027 | Safety Evaluation of Aminophylline and Methazolamide | Completed | Poudre Valley Health System | Phase 1 | This safety study is the first in a series of studies testing the application of the combination of aminophylline and methazolamide. |
| NCT01702025 | Rapid Acclimatization to Hypoxia at Altitude | Completed | Defense Advanced Research Projects Agency | Phase 1/Phase 2 | In low oxygen environments, such as altitude, some adults may become ill and suffer from acute mountain sickness. Further, all adults will find that exercising becomes much more difficult when compared with exercise at lower altitudes (e.g. sea-level). The purpose of this investigation is to study the effects of two drugs that may help people adjust to high-altitude quickly, prevent them from becoming ill and improve their exercise performance. The drugs are Methazolamide and Aminophylline. |
| Trial ID | Title | Status | Sponsor | Phase | Summary |
Clinical Trial Conditions for Methazolamide
Condition Name
Clinical Trial Locations for Methazolamide
Trials by Country
Clinical Trial Progress for Methazolamide
Clinical Trial Phase
Clinical Trial Sponsors for Methazolamide
Sponsor Name
